Advanced search

Inhibition of tamoxifen's therapeutic benefit by tangeretin in mammary cancer.

(2000) EUROPEAN JOURNAL OF CANCER. 36(Suppl. 4). p.S73-S73
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Depypere, Herman, Marc Bracke, Tom Boterberg, MARCUS MAREEL, M NUYTINCK, K VENNEKENS, and Rudolphe Serreyn. 2000. “Inhibition of Tamoxifen’s Therapeutic Benefit by Tangeretin in Mammary Cancer.” European Journal of Cancer 36 (Suppl. 4): S73–S73.
APA
Depypere, H., Bracke, M., Boterberg, T., MAREEL, M., NUYTINCK, M., VENNEKENS, K., & Serreyn, R. (2000). Inhibition of tamoxifen’s therapeutic benefit by tangeretin in mammary cancer. EUROPEAN JOURNAL OF CANCER, 36(Suppl. 4), S73–S73.
Vancouver
1.
Depypere H, Bracke M, Boterberg T, MAREEL M, NUYTINCK M, VENNEKENS K, et al. Inhibition of tamoxifen’s therapeutic benefit by tangeretin in mammary cancer. EUROPEAN JOURNAL OF CANCER. 2000;36(Suppl. 4):S73–S73.
MLA
Depypere, Herman, Marc Bracke, Tom Boterberg, et al. “Inhibition of Tamoxifen’s Therapeutic Benefit by Tangeretin in Mammary Cancer.” EUROPEAN JOURNAL OF CANCER 36.Suppl. 4 (2000): S73–S73. Print.
@article{173093,
  author       = {Depypere, Herman and Bracke, Marc and Boterberg, Tom and Mareel, Marcus and NUYTINCK, M and VENNEKENS, K and Serreyn, Rudolphe},
  issn         = {0959-8049},
  journal      = {EUROPEAN JOURNAL OF CANCER},
  language     = {eng},
  number       = {Suppl. 4},
  pages        = {S73--S73},
  title        = {Inhibition of tamoxifen's therapeutic benefit by tangeretin in mammary cancer.},
  volume       = {36},
  year         = {2000},
}

Web of Science
Times cited: